EXXRF logo

EXXRF Exor N.V.

Other OTC · Auto - Manufacturers · Consumer Cyclical

$80.70
+0.07 (+0.09%)

Exor N.V. is a diversified holding company with a global footprint, primarily operating across several key sectors. Its broad portfolio encompasses luxury goods, the automotive industry, agricultural and construction machinery, commercial vehicles, and professional sports. Within the premium segment, Exor specializes in the development, engineering, production, and worldwide sale of high-performan…

Market Cap: $16.32Bwww.exor.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 11Aug 11

Quote

Day Range
$80.70 – $82.50
52-Week Range
$73.00 – $104.00
Volume
$1.7K
Market Cap
$16.32B
50-Day Avg
$78.43
200-Day Avg
$81.64
Prev Close
$80.63
Open
$80.70

Valuation & Ratios

P/E Ratio
-3.89
EPS
$-18.48
P/B Ratio
0.49
P/S Ratio
14.17
Debt/Equity
0.12
Current Ratio
16.87
Dividend Yield
+0.6%
Gross Margin
+98.1%

Returns & Efficiency

Return on Equity
-12.5%
Return on Assets
-10.2%
FCF Yield
+19.4%
EV/EBITDA
-3.82

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$1.04B$-3.79B$-18.48
2024$15.39B$14.67B$68.27
2023$44.74B$4.19B$18.38
2022$41.84B$4.23B$12.43
2021$33.62B$1.72B$7.33

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Tue, Sep 22(in 5 weeks)

Estimates and results for EXXRF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

EXXRFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsreuters.com·4d ago·Neutral

    Agnelli family's Exor can raise Philips stake to 22% under updated agreement Philips' largest shareholder Exor , the investment arm of Italy's Agnelli family, has ​extended its agreement with the health ‌technology firm, giving it the flexibility to increase its stake to up to 22%, the ​companies said on Tuesday.

    View source ↗